Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions.
We all loved Michael deeply and will miss him very much.
The Braverman-Kelmenson Liposarcoma Research Fund was established by Michael's mother in 2022 to support liposarcoma research at Dana-Farber Cancer Institute. Under the leadership of Dr. George Demetri, the fund provides vital resources to advance liposarcoma research and care.
The Braverman and Kelmenson families sincerely appreciate your consideration of a gift in Michael's memory.